NCT00239304 Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00238368 Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant Status COMPLETED Phase PHASE2
NCT00238160 Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer Status WITHDRAWN Phase PHASE3
NCT00237575 Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer Status TERMINATED Phase PHASE3
NCT00234494 Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer Status COMPLETED Phase PHASE2
NCT00231842 Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus Status COMPLETED Phase PHASE2
NCT00230451 Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma Status COMPLETED Phase PHASE2
NCT00229723 IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00227630 Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE2
NCT00227539 Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00226239 Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00217698 Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00216125 Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00216008 Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation. Status TERMINATED Phase PHASE2
NCT00215995 Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas Status COMPLETED Phase PHASE2
NCT00215644 Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer Status COMPLETED Phase PHASE2
NCT00215514 Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase EARLY_PHASE1
NCT00215501 Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00210041 Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma Status COMPLETED Phase PHASE2
NCT00201760 Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2